Literature DB >> 27043011

Identifying Interactions that Determine Fragment Binding at Protein Hotspots.

Chris J Radoux1,2, Tjelvar S G Olsson1,3, Will R Pitt4, Colin R Groom1, Tom L Blundell2.   

Abstract

Locating a ligand-binding site is an important first step in structure-guided drug discovery, but current methods do little to suggest which interactions within a pocket are the most important for binding. Here we illustrate a method that samples atomic hotspots with simple molecular probes to produce fragment hotspot maps. These maps specifically highlight fragment-binding sites and their corresponding pharmacophores. For ligand-bound structures, they provide an intuitive visual guide within the binding site, directing medicinal chemists where to grow the molecule and alerting them to suboptimal interactions within the original hit. The fragment hotspot map calculation is validated using experimental binding positions of 21 fragments and subsequent lead molecules. The ligands are found in high scoring areas of the fragment hotspot maps, with fragment atoms having a median percentage rank of 97%. Protein kinase B and pantothenate synthetase are examined in detail. In each case, the fragment hotspot maps are able to rationalize a Free-Wilson analysis of SAR data from a fragment-based drug design project.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27043011     DOI: 10.1021/acs.jmedchem.5b01980

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  24 in total

1.  Docking-based structural splicing and reassembly strategy to develop novel deazapurine derivatives as potent B-RafV600E inhibitors.

Authors:  Gui-Min Wang; Xiang Wang; Jian-Ming Zhu; Bin-Bin Guo; Zhuo Yang; Zhi-Jian Xu; Bo Li; He-Yao Wang; Ling-Hua Meng; Wei-Liang Zhu; Jian Ding
Journal:  Acta Pharmacol Sin       Date:  2017-04-17       Impact factor: 6.150

2.  Interaction Energetics and Druggability of the Protein-Protein Interaction between Kelch-like ECH-Associated Protein 1 (KEAP1) and Nuclear Factor Erythroid 2 Like 2 (Nrf2).

Authors:  Mengqi Zhong; Andrew Lynch; Samantha N Muellers; Stefan Jehle; Lingqi Luo; David R Hall; Reina Iwase; James P Carolan; Megan Egbert; Amanda Wakefield; Kristina Streu; Christine M Harvey; Paula C Ortet; Dima Kozakov; Sandor Vajda; Karen N Allen; Adrian Whitty
Journal:  Biochemistry       Date:  2020-01-02       Impact factor: 3.162

3.  Identification and characterization of fragment binding sites for allosteric ligand design using the site identification by ligand competitive saturation hotspots approach (SILCS-Hotspots).

Authors:  Alexander D MacKerell; Sunhwan Jo; Sirish Kaushik Lakkaraju; Christoffer Lind; Wenbo Yu
Journal:  Biochim Biophys Acta Gen Subj       Date:  2020-01-03       Impact factor: 3.770

4.  Benchmark Sets for Binding Hot Spot Identification in Fragment-Based Ligand Discovery.

Authors:  Amanda E Wakefield; Christine Yueh; Dmitri Beglov; Marcelo S Castilho; Dima Kozakov; György M Keserű; Adrian Whitty; Sandor Vajda
Journal:  J Chem Inf Model       Date:  2020-12-08       Impact factor: 4.956

Review 5.  Incorporating Target-Specific Pharmacophoric Information into Deep Generative Models for Fragment Elaboration.

Authors:  Thomas E Hadfield; Fergus Imrie; Andy Merritt; Kristian Birchall; Charlotte M Deane
Journal:  J Chem Inf Model       Date:  2022-05-02       Impact factor: 6.162

Review 6.  Protein crystallography and drug discovery: recollections of knowledge exchange between academia and industry.

Authors:  Tom L Blundell
Journal:  IUCrJ       Date:  2017-06-29       Impact factor: 4.769

7.  Identification of new allosteric sites and modulators of AChE through computational and experimental tools.

Authors:  Carlos Roca; Carlos Requena; Víctor Sebastián-Pérez; Sony Malhotra; Chris Radoux; Concepción Pérez; Ana Martinez; Juan Antonio Páez; Tom L Blundell; Nuria E Campillo
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

8.  Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19.

Authors:  Martin A Redhead; C David Owen; Lennart Brewitz; Amelia H Collette; Petra Lukacik; Claire Strain-Damerell; Sean W Robinson; Patrick M Collins; Philipp Schäfer; Mark Swindells; Chris J Radoux; Iva Navratilova Hopkins; Daren Fearon; Alice Douangamath; Frank von Delft; Tika R Malla; Laura Vangeel; Thomas Vercruysse; Jan Thibaut; Pieter Leyssen; Tu-Trinh Nguyen; Mitchell Hull; Anthony Tumber; David J Hallett; Christopher J Schofield; David I Stuart; Andrew L Hopkins; Martin A Walsh
Journal:  Sci Rep       Date:  2021-06-24       Impact factor: 4.379

9.  Decoding the similarities and differences among mycobacterial species.

Authors:  Sony Malhotra; Sundeep Chaitanya Vedithi; Tom L Blundell
Journal:  PLoS Negl Trop Dis       Date:  2017-08-30

10.  Computer-aided molecular design of pyrazolotriazines targeting glycogen synthase kinase 3.

Authors:  M Lourdes Sciú; Victor Sebastián-Pérez; Loreto Martinez-Gonzalez; Rocio Benitez; Daniel I Perez; Concepción Pérez; Nuria E Campillo; Ana Martinez; E Laura Moyano
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.